Literature DB >> 9061273

Tea and cancer: a review of the epidemiological evidence.

W J Blot1, W H Chow, J K McLaughlin.   

Abstract

Numerous recent reports of inhibition of carcinogenesis in experimental animals by tea or tea compounds raise the possibility that tea drinking may lower cancer risk in humans. Thus, studies around the world were reviewed to evaluate whether there is a consensus of epidemiologic evidence on the relation of tea drinking to cancer overall or to specific cancers. Ecological data suggest at most a modest benefit, since there is considerable international variation in tea consumption but generally small differences in cancer rates. More relevant case-control and cohort studies show mixed results. Detailed data from these studies on cancer risks according to amount and duration of tea intake are quite limited, and consistent dose-related patterns. have yet to emerge. Nevertheless, several investigations point to the possibility of lowered risks of digestive tract cancers among tea drinkers, especially those consuming green tea. Further research, particularly in population with wide ranges of tea consumption, is needed before definitive conclusions on tea's impact upon cancer risk can be reached.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9061273

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  14 in total

1.  Maternal tea consumption during early pregnancy and the risk of spina bifida.

Authors:  Mahsa M Yazdy; Sarah C Tinker; Allen A Mitchell; Laurie A Demmer; Martha M Werler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-05-29

2.  Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.

Authors:  Imtiaz A Siddiqui; Mohammad Asim; Bilal B Hafeez; Vaqar M Adhami; Rohinton S Tarapore; Hasan Mukhtar
Journal:  FASEB J       Date:  2010-12-21       Impact factor: 5.191

3.  Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality.

Authors:  M Woodward; H Tunstall-Pedoe
Journal:  J Epidemiol Community Health       Date:  1999-08       Impact factor: 3.710

Review 4.  Chemoprevention of head and neck cancer.

Authors:  Katrina Y Glover; Vali A Papadimitrakopoulou
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

5.  Molecular mechanisms of green tea polyphenols.

Authors:  Q Ping Dou
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols.

Authors:  Madhulika Singh; Shilpa Tyagi; Kulpreet Bhui; Sahdeo Prasad; Yogeshwer Shukla
Journal:  Invest New Drugs       Date:  2009-03-07       Impact factor: 3.850

7.  Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.

Authors:  Molly Lang; Roger Henson; Chiara Braconi; Tushar Patel
Journal:  Liver Int       Date:  2009-02-17       Impact factor: 5.828

8.  The effect of green tea on oxidative damage and tumour formation in Lobund-Wistar rats.

Authors:  Jacintha O'Sullivan; Juliette Sheridan; Hugh Mulcahy; Martin Tenniswood; Colm Morrissey
Journal:  Eur J Cancer Prev       Date:  2008-11       Impact factor: 2.497

Review 9.  Inhibition of carcinogenesis by tea constituents.

Authors:  Jihyeung Ju; Gang Lu; Joshua D Lambert; Chung S Yang
Journal:  Semin Cancer Biol       Date:  2007-07-04       Impact factor: 15.707

10.  Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population.

Authors:  Amit Kumar Mitra; Neetu Singh; Vivek Kumar Garg; Rashmi Chaturvedi; Mandira Sharma; Srikanta Kumar Rath
Journal:  J Exp Clin Cancer Res       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.